A 22 minute video from Dr. Livingood on methods he claims raise the body's own GLP-1. The claims are his own and aren't backed by trial data in the video.
Recap by typeshit. Full story at Dr. Livingood.
U of T researchers built the AI tool with the aim of speeding up how new peptide drugs are found. The university's announcement has the details.
Fractyl plans to file a De Novo request with the FDA in late Q4, yet its shares closed about 63% lower that day over a class action and doubts about 12-month results.
Health records from 131 million adults linked GLP-1s to fewer dialysis or transplant cases. The researchers stress the study is observational and can't prove cause.
Centre Daily Times looks at how peptides taken by mouth can get past the gut intact and reach specific spots in the body, a key hurdle for pill versions of these drugs.
Medscape reports strong weight loss results for teens on GLP-1 medications, while noting there's still little data on long-term effects or growth.
US Anti-Doping's Dr Matt Fedoruk gives athletes a short rundown on peptides, covering what is prohibited in sport and what is allowed.
Loading…